GHRP-2 Peptide 5mg

GHRP-2 Peptide 5mg: Product Overview

GHRP-2 Peptide 5mg, also known as Pralmorelin or KP-102, is a synthetic hexapeptide classified as a growth hormone secretagogue. Developed for research into endocrine function, GHRP-2 interacts with the ghrelin receptor (GHS-R1a) and has been investigated for its ability to stimulate endogenous growth hormone (GH) secretion.

GHRP-2 is a distinct compound from GHRP-6, Ipamorelin and recombinant human growth hormone. Its defined six-residue structure makes it relevant to research involving peptide-receptor interactions and pituitary signaling. The 5mg designation identifies the stated peptide quantity in this product listing.

GHRP-2 5mg Product Specifications

• Product Name: GHRP-2 Peptide 5mg
• Full Name: Growth Hormone Releasing Peptide-2
• Alternative Names: Pralmorelin, KP-102
• Peptide Type: Synthetic hexapeptide
• Classification: Growth hormone secretagogue
• Listed Quantity: 5mg
• CAS Number: 158861-67-7
• Molecular Formula: C45H55N9O6
• Molecular Weight: Approximately 818.0 g/mol
• Peptide Sequence: H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
• Category: Research Peptides

The molecular information describes the reference Pralmorelin structure. Salt forms and specific product formulations may have different compositional specifications. Confirm the actual supplied form through the product label and batch documentation.

What Is GHRP-2 Peptide?

GHRP-2 is a synthetic peptide composed of six amino acid residues, including modified amino acids. It was developed through research into growth hormone-releasing compounds and their interactions with endocrine signaling pathways.

Unlike recombinant human growth hormone (HGH), GHRP-2 does not supply the growth hormone protein itself. Instead, it activates receptor pathways associated with endogenous hormone secretion.

GHRP-2 has been investigated in experimental and clinical research involving growth hormone responses and pituitary function.

Key Characteristics of GHRP-2

• Growth Hormone Secretagogue: Investigated for stimulation of endogenous growth hormone release.
• Ghrelin Receptor Activity: Interacts with GHS-R1a, a receptor involved in growth hormone and metabolic signaling.
• Defined Peptide Structure: A characterized synthetic hexapeptide with modified amino acid residues.
• Endocrine Research: Studied in investigations of pituitary hormone responses and neuroendocrine signaling.
• 5mg Presentation: Clearly identified peptide quantity for research documentation and product cataloging.

GHRP-2 Mechanism of Action

GHRP-2 acts as an agonist of the growth hormone secretagogue receptor GHS-R1a, also known as the ghrelin receptor.

Activation of this receptor influences signaling pathways associated with growth hormone secretion. Research has examined GHRP-2 activity in relation to pituitary function and interactions with the growth hormone-releasing hormone system.

Studies have also investigated effects on other endocrine markers, including prolactin, ACTH and cortisol. These responses help distinguish the compound's pharmacological profile from that of more selective secretagogues.

GHRP-2 Peptide Research Background

Scientific studies involving GHRP-2 have evaluated growth hormone secretion, ghrelin receptor activity, pituitary responses and endocrine regulation.

Pralmorelin has also been investigated in diagnostic testing of growth hormone secretory function. Research findings from specific pharmaceutical preparations should not be generalized to separately supplied peptide catalog products.

The safety and effectiveness of independently supplied GHRP-2 products for bodybuilding, performance enhancement or other non-established applications have not been demonstrated.

GHRP-2 vs GHRP-6: Key Differences

GHRP-2 and GHRP-6 are related synthetic growth hormone secretagogues, but their molecular structures and biological activity profiles differ.

• GHRP-2: Also known as Pralmorelin, it has been studied for growth hormone secretion and pituitary diagnostic applications.
• GHRP-6: Another synthetic hexapeptide investigated for growth hormone secretion and appetite-related signaling.
• Key Difference: Their amino acid sequences, experimental endocrine responses and research histories are not identical.

These peptides should be evaluated separately rather than treated as interchangeable compounds.

GHRP-2 vs Ipamorelin

GHRP-2 and Ipamorelin both interact with the ghrelin receptor and have been investigated for growth hormone secretagogue activity.

GHRP-2 is a synthetic hexapeptide with a documented history in pituitary research. Ipamorelin is a synthetic pentapeptide investigated for relatively selective growth hormone release.

Their different structures and endocrine activity profiles are important when comparing research involving these compounds.

GHRP-2 vs Human Growth Hormone (HGH)

GHRP-2 and recombinant human growth hormone are fundamentally different molecules.

• GHRP-2: A six-residue peptide that activates receptor pathways associated with endogenous growth hormone secretion.
• HGH: A 191-amino-acid protein hormone involved in growth, metabolism and endocrine regulation.
• Primary Distinction: GHRP-2 influences hormone-releasing signaling, while recombinant HGH supplies the hormone itself.

GHRP-2 5mg Packaging and Documentation

The GHRP-2 Peptide 5mg listing identifies a stated quantity of peptide material. Product evaluation should include verification of the original packaging, declared peptide identity, chemical form and available batch-specific analytical documentation.

Relevant documentation may include identity analysis, purity information and formulation-specific storage requirements. Reference molecular characteristics alone do not establish the quality of an individual supplied batch.